Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 38467357)

  • 21. Tylophorine, a phenanthraindolizidine alkaloid isolated from Tylophora indica exerts antiangiogenic and antitumor activity by targeting vascular endothelial growth factor receptor 2-mediated angiogenesis.
    Saraswati S; Kanaujia PK; Kumar S; Kumar R; Alhaider AA
    Mol Cancer; 2013 Jul; 12():82. PubMed ID: 23895055
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Carvedilol may attenuate liver cirrhosis by inhibiting angiogenesis through the VEGF-Src-ERK signaling pathway.
    Ding Q; Tian XG; Li Y; Wang QZ; Zhang CQ
    World J Gastroenterol; 2015 Aug; 21(32):9566-76. PubMed ID: 26327764
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Isolinderalactone suppresses human glioblastoma growth and angiogenic activity in 3D microfluidic chip and in vivo mouse models.
    Park JH; Kim MJ; Kim WJ; Kwon KD; Ha KT; Choi BT; Lee SY; Shin HK
    Cancer Lett; 2020 May; 478():71-81. PubMed ID: 32173479
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The natural compound codonolactone impairs tumor induced angiogenesis by downregulating BMP signaling in endothelial cells.
    Wang S; Cai R; Ma J; Liu T; Ke X; Lu H; Fu J
    Phytomedicine; 2015 Oct; 22(11):1017-26. PubMed ID: 26407944
    [TBL] [Abstract][Full Text] [Related]  

  • 25. 4-Acetylantroquinonol B Suppresses Prostate Cancer Growth and Angiogenesis via a VEGF/PI3K/ERK/mTOR-Dependent Signaling Pathway in Subcutaneous Xenograft and In Vivo Angiogenesis Models.
    Huang TF; Wang SW; Lai YW; Liu SC; Chen YJ; Hsueh TY; Lin CC; Lin CH; Chung CH
    Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163369
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Knockout of αA-crystallin inhibits ocular neovascularization.
    Xu Q; Bai Y; Huang L; Zhou P; Yu W; Zhao M
    Invest Ophthalmol Vis Sci; 2015 Jan; 56(2):816-26. PubMed ID: 25574047
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dual blockade of VEGFR1 and VEGFR2 by a novel peptide abrogates VEGF-driven angiogenesis, tumor growth, and metastasis through PI3K/AKT and MAPK/ERK1/2 pathway.
    Sadremomtaz A; Mansouri K; Alemzadeh G; Safa M; Rastaghi AE; Asghari SM
    Biochim Biophys Acta Gen Subj; 2018 Dec; 1862(12):2688-2700. PubMed ID: 30251659
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Alkaloid extract of Corydalis yanhusuo inhibits angiogenesis via targeting vascular endothelial growth factor receptor signaling.
    Wan L; Zhao Y; Zhang Q; Gao G; Zhang S; Gao Y; Chen X; Qian X
    BMC Complement Altern Med; 2019 Dec; 19(1):359. PubMed ID: 31823762
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antiangiogenic and antitumor potential of berbamine, a natural CaMKIIγ inhibitor, against glioblastoma.
    Kim YJ; Han JM; Jung HJ
    Biochem Biophys Res Commun; 2021 Aug; 566():129-134. PubMed ID: 34119825
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dianhydrogalactitol, a potential multitarget agent, inhibits glioblastoma migration, invasion, and angiogenesis.
    Jiang X; Huang Y; Wang X; Liang Q; Li Y; Li F; Fu X; Huang C; Liu H
    Biomed Pharmacother; 2017 Jul; 91():1065-1074. PubMed ID: 28525947
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Proteasome inhibition with bortezomib induces cell death in GBM stem-like cells and temozolomide-resistant glioma cell lines, but stimulates GBM stem-like cells' VEGF production and angiogenesis.
    Bota DA; Alexandru D; Keir ST; Bigner D; Vredenburgh J; Friedman HS
    J Neurosurg; 2013 Dec; 119(6):1415-23. PubMed ID: 24093630
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinically relevant concentrations of lidocaine inhibit tumor angiogenesis through suppressing VEGF/VEGFR2 signaling.
    Gao J; Hu H; Wang X
    Cancer Chemother Pharmacol; 2019 Jun; 83(6):1007-1015. PubMed ID: 30887179
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Plumbagin inhibits tumour angiogenesis and tumour growth through the Ras signalling pathway following activation of the VEGF receptor-2.
    Lai L; Liu J; Zhai D; Lin Q; He L; Dong Y; Zhang J; Lu B; Chen Y; Yi Z; Liu M
    Br J Pharmacol; 2012 Feb; 165(4b):1084-96. PubMed ID: 21658027
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evodiamine exerts anti-tumor effects against hepatocellular carcinoma through inhibiting β-catenin-mediated angiogenesis.
    Shi L; Yang F; Luo F; Liu Y; Zhang F; Zou M; Liu Q
    Tumour Biol; 2016 Sep; 37(9):12791-12803. PubMed ID: 27449032
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Exosome-transmitted ANGPTL1 suppresses angiogenesis in glioblastoma by inhibiting the VEGFA/VEGFR2/Akt/eNOS pathway.
    Wang D; Li H; Zeng T; Chen Q; Huang W; Huang Y; Liao Y; Jiang Q
    J Neuroimmunol; 2024 Feb; 387():578266. PubMed ID: 38150891
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Asiatic acid inhibits angiogenesis and vascular permeability through the VEGF/VEGFR2 signaling pathway to inhibit the growth and metastasis of breast cancer in mice.
    Tian M; Chen K; Huang J; Chu D; Li J; Huang K; Ma C
    Phytother Res; 2021 Nov; 35(11):6389-6400. PubMed ID: 34541711
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Preclinical characterization of anlotinib, a highly potent and selective vascular endothelial growth factor receptor-2 inhibitor.
    Xie C; Wan X; Quan H; Zheng M; Fu L; Li Y; Lou L
    Cancer Sci; 2018 Apr; 109(4):1207-1219. PubMed ID: 29446853
    [TBL] [Abstract][Full Text] [Related]  

  • 38. DCT015, a new sorafenib derivate, inhibits tumor growth and angiogenesis in gastric cancer models.
    Wang W; Wang H; Ni Y; Yao Z; Ye L; Tian J
    Tumour Biol; 2016 Jul; 37(7):9221-32. PubMed ID: 26768619
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Daphnetin inhibits TNF-α and VEGF-induced angiogenesis through inhibition of the IKKs/IκBα/NF-κB, Src/FAK/ERK1/2 and Akt signalling pathways.
    Kumar A; Sunita P; Jha S; Pattanayak SP
    Clin Exp Pharmacol Physiol; 2016 Oct; 43(10):939-50. PubMed ID: 27297262
    [TBL] [Abstract][Full Text] [Related]  

  • 40. PE, a new sulfated saponin from sea cucumber, exhibits anti-angiogenic and anti-tumor activities in vitro and in vivo.
    Tian F; Zhang X; Tong Y; Yi Y; Zhang S; Li L; Sun P; Lin L; Ding J
    Cancer Biol Ther; 2005 Aug; 4(8):874-82. PubMed ID: 16082187
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.